Understanding Liquid Biopsies for MBC
A liquid biopsy is a blood test that looks for cancer cells or pieces of cancer DNA. Researchers are studying how to use liquid biopsies to learn about and treat MBC. Learn more here.
A liquid biopsy is a blood test that looks for cancer cells or pieces of cancer DNA. Researchers are studying how to use liquid biopsies to learn about and treat MBC. Learn more here.
Clinical trials have resulted in information about new biomarkers that can now be used to guide MBC treatment decisions. Read more here.
Biomarker testing is important for everyone with MBC. A clinical trial may be a way to get biomarker testing for free. Read here to learn when to have biomarker testing, how to have it paid for, and clinical trials that are studying biomarker testing.
Biomarker testing is important for everyone with MBC. A clinical trial may be a way to get biomarker testing for free. Read here to learn when to have biomarker testing, how to have it paid for, and clinical trials that are studying biomarker testing.
Researchers are working to understand the complex reasons for differences in MBC outcomes. Understanding these differences could allow for more personalized treatment. Learn more here.
In part 3 of a 3-part series, learn about biomarkers that require more research before being recommended to guide treatment decisions.
In part 2 of a 3-part series, read about the new recommendations and the dMMR/MSI-H, TMB, and NTRK fusion biomarkers.
In this part 1 of a 3-part series, read about new recommendations for using biomarkers to make MBC treatment decisions.
Pharmacogenomics helps explain how your genes affect your body’s response to MBC treatment. Read more about how it is being studied in MBC clinical research.
Learn more about BRCA1/2 testing for Black women diagnosed with breast cancer and other related resources about Black & BRCA.